Lifetime Vision Source Medicare Supplier Location: 1160 W Elm Ave, Hermiston, Oregon 97838 Phone: (541) 567-6623 |
Good Shepherd Health Care System Durable Medical Equipment & Medical Supplies Location: 435 Nw 11th St, Hermiston, Oregon 97838 Phone: (541) 667-3477 |
Safeway Pharmacy #0444 Durable Medical Equipment & Medical Supplies Location: 990 Hwy 395 S, Hermiston, Oregon 97838 Phone: (541) 564-1285 |
Rite Aid Pharmacy 05397 Durable Medical Equipment & Medical Supplies Location: 835 S Highway 395, Hermiston, Oregon 97838 Phone: (541) 567-7805 |
Wal-mart Pharmacy 10-1817 Durable Medical Equipment & Medical Supplies Location: 1350 N 1st St, Hermiston, Oregon 97838 Phone: (541) 567-5323 |
News Archive
The 3rd European Multidisciplinary Meeting on Urological Cancers will kick off this Friday, bringing together representatives of three adjacent fields involved in the management of prostate, bladder, kidney, testicular and penile cancer.
"The global financial crisis has led to an alarming rate of urban malnutrition in the south of the Central African Republic, where diamond mines have closed as demand for the gems falls, the medical relief group Medecins Sans Frontieres (MSF) says," Reuters AlertNet reports (Fominyen, 9/24). In a related blog post, Reuters AlertNet writes that aid agencies are warning that without additional support from donors, the Central African Republic could "start sliding backwards after three years of progress at a time when humanitarian assistance was raised" (Fominyen [2], 9/24).
AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that AlloWrap DS, its double-sided human amniotic membrane allograft, has been moved to the high-cost reimbursement category.
Lois Quam, executive director of the Obama administration's Global Health Initiative (GHI), talked about GHI projects and "defended the program even if her panel was met with some hard questions" during a presentation on Tuesday at the annual Global Health Council conference in Washington, D.C., GlobalPost's "Global Pulse" blog reports.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
› Verified 5 days ago